Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Knowing when to start saving for retirement is essential for financial security. Explore the best timing for your savings plan.
24,441 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
The U.S. launched a new round of strikes against Iran, triggering swift market reactions and renewed concerns about a...
A CBS Philadelphia anchor became a reminder that scammers exploit trusted voices. Learn how the philadelphia anchor s...
The Trump administration presses more to accelerate domestic memory fabrication, aiming to reduce reliance on oversea...
Micron Technology sits around $905 as the AI memory stock rally faces questions. Here are three reasons investors may...
As lawmakers race toward two July floor windows, the CLARITY Act stands as the key to how digital assets are classifi...
In a world of slim yields, five dividend stocks yielding more than 5% offer a chance for meaningful passive income. T...
When insiders move shares, investors want to know why. This comprehensive guide breaks down why the electronic arts p...
Three AI models weigh XRP vs Bitcoin for a $10,000 crypto bet in 2026. The forecasts highlight upside potential again...
Vale’s shares fell as iron ore demand in China cooled, signaling wider margin pressures for metals. This guide breaks...
A Trump-linked figure renews a $1 million bitcoin target at the World Liberty Forum, reigniting debate as ETF flow an...
Garmin stock soared this week after the GPS giant posted a solid Q4 and guided higher for 2026. This article breaks d...